Bank of America Corp DE Purchases 68,593 Shares of Henry Schein, Inc. $HSIC

Bank of America Corp DE grew its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 5.9% in the first quarter, Holdings Channel reports. The firm owned 1,221,585 shares of the company’s stock after purchasing an additional 68,593 shares during the period. Bank of America Corp DE’s holdings in Henry Schein were worth $90,031,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Invesco Ltd. grew its position in Henry Schein by 4.1% during the third quarter. Invesco Ltd. now owns 4,731,698 shares of the company’s stock worth $314,043,000 after buying an additional 184,763 shares in the last quarter. Southpoint Capital Advisors LP raised its holdings in shares of Henry Schein by 28.0% in the 1st quarter. Southpoint Capital Advisors LP now owns 3,200,000 shares of the company’s stock valued at $235,840,000 after acquiring an additional 700,000 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Henry Schein by 2.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,873,004 shares of the company’s stock valued at $211,734,000 after acquiring an additional 56,687 shares during the last quarter. Ameriprise Financial Inc. boosted its position in shares of Henry Schein by 11.3% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,523,014 shares of the company’s stock valued at $167,453,000 after acquiring an additional 256,156 shares during the last quarter. Finally, Bank of Montreal Can grew its holdings in shares of Henry Schein by 3,655.7% during the fourth quarter. Bank of Montreal Can now owns 2,144,773 shares of the company’s stock worth $162,102,000 after purchasing an additional 2,087,666 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $88.13 on Friday. The company has a current ratio of 1.32, a quick ratio of 0.75 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $9.82 billion, a PE ratio of 25.69, a price-to-earnings-growth ratio of 1.68 and a beta of 0.80. The business’s 50-day moving average price is $83.49 and its 200-day moving average price is $78.67. Henry Schein, Inc. has a 12 month low of $61.94 and a 12 month high of $92.18.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 4th. The company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.03. Henry Schein had a return on equity of 15.97% and a net margin of 2.96%.The business had revenue of $3.46 billion during the quarter, compared to analyst estimates of $3.37 billion. During the same quarter in the prior year, the firm earned $1.10 earnings per share. Henry Schein’s revenue for the quarter was up 6.7% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. Sell-side analysts forecast that Henry Schein, Inc. will post 5.35 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms recently weighed in on HSIC. BTIG Research restated a “buy” rating and issued a $100.00 price objective on shares of Henry Schein in a research report on Wednesday. Citigroup reiterated a “buy” rating and set a $112.00 target price (up from $100.00) on shares of Henry Schein in a research report on Wednesday. Stifel Nicolaus set a $95.00 price target on shares of Henry Schein in a research note on Wednesday. Mizuho decreased their price target on shares of Henry Schein from $88.00 to $82.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Finally, BMO Capital Markets began coverage on shares of Henry Schein in a research report on Wednesday, July 8th. They set a “market perform” rating and a $85.00 price objective on the stock. Eight analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $92.27.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Director William K. Daniel acquired 10,000 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was bought at an average price of $69.19 per share, with a total value of $691,900.00. Following the purchase, the director owned 20,000 shares of the company’s stock, valued at approximately $1,383,800. This trade represents a 100.00% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.89% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.